IC

Ikarian Capital Portfolio holdings

AUM $699M
1-Year Est. Return 600.17%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+600.17%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$699M
AUM Growth
-$73.6M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
169
New
Increased
Reduced
Closed

Top Buys

1 +$30.3M
2 +$15.8M
3 +$14.1M
4
CLDX icon
Celldex Therapeutics
CLDX
+$12.6M
5
BBIO icon
BridgeBio Pharma
BBIO
+$11.6M

Top Sells

1 +$60.4M
2 +$25.8M
3 +$22.5M
4
ABVX
Abivax
ABVX
+$17.6M
5
AMGN icon
Amgen
AMGN
+$14.7M

Sector Composition

1 Healthcare 99.35%
2 Financials 0.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TERN
1
DELISTED
Terns Pharmaceuticals
TERN
$76.8M 10.98%
1,456,378
-140,000
KOD icon
2
Kodiak Sciences
KOD
$2.08B
$48.3M 6.9%
1,265,795
+546,008
ALMS
3
Alumis Inc
ALMS
$2.55B
$26.7M 3.82%
+1,213,548
PCVX icon
4
Vaxcyte
PCVX
$6.85B
$24.9M 3.56%
428,682
+50,000
PRAX icon
5
Praxis Precision Medicines
PRAX
$7.19B
$23.1M 3.3%
71,581
-15,000
HROW icon
6
Harrow
HROW
$1.22B
$19.1M 2.74%
543,047
+359,700
RLMD icon
7
Relmada Therapeutics
RLMD
$673M
$18.7M 2.68%
2,688,359
-380,000
CYTK icon
8
Cytokinetics
CYTK
$9.63B
$18.7M 2.67%
283,572
+110,900
TENX icon
9
Tenax Therapeutics
TENX
$290M
$16.3M 2.33%
1,017,600
+50,000
CAPR icon
10
Capricor Therapeutics
CAPR
$1.58B
$16.1M 2.3%
528,015
-50,000
RVMD icon
11
Revolution Medicines
RVMD
$32.2B
$15.9M 2.27%
163,142
+25,000
CLDX icon
12
Celldex Therapeutics
CLDX
$2.27B
$14.6M 2.09%
+461,247
PHVS icon
13
Pharvaris
PHVS
$2.03B
$13.8M 1.97%
486,856
CNTB
14
Connect Biopharma Holdings
CNTB
$135M
$13.1M 1.88%
5,388,486
+600,000
DRUG
15
Bright Minds Biosciences
DRUG
$753M
$12.2M 1.74%
166,647
+7,226
BBIO icon
16
BridgeBio Pharma
BBIO
$12.5B
$11.9M 1.7%
+160,120
ORKA
17
Oruka Therapeutics
ORKA
$3.33B
$11.9M 1.7%
+242,021
ANRO icon
18
Alto Neuroscience
ANRO
$657M
$11.6M 1.66%
515,000
SLNO
19
DELISTED
Soleno Therapeutics
SLNO
$11.5M 1.65%
344,123
+275,300
MAZE
20
Maze Therapeutics
MAZE
$1.34B
$11.3M 1.62%
378,999
-265,681
ANIP icon
21
ANI Pharmaceuticals
ANIP
$1.7B
$11.3M 1.62%
+147,085
CTNM
22
Contineum Therapeutics
CTNM
$463M
$10.6M 1.51%
807,874
+525,000
RARE icon
23
Ultragenyx Pharmaceutical
RARE
$2.15B
$10.1M 1.45%
482,571
+469,900
IONS icon
24
Ionis Pharmaceuticals
IONS
$12.1B
$9.54M 1.36%
127,038
-75,000
OLMA icon
25
Olema Pharmaceuticals
OLMA
$934M
$8.92M 1.28%
598,281
-160,373